Abstract
Hypoxanthine-guanine phosphoribosyltransferase (EC 2.4.2.8.; HPRT) catalyzes the salvage synthesis of inosine-5′-monophosphate (IMP) and guanosine-5′-monophosphate (GMP) from the purine bases hypoxanthine and guanine, respectively. Complete deficiency of HPRT activity is associated with the Lesch-Nyhan syndrome (LNS), characterized by excessive purine production and severe neurological manifestations. The etiology of the metabolic consequences of HPRT deficiency is clarified, but that of the neurological manifestations is not yet understood. HPRT-deficient mice represent an experimental animal model of LNS. In search for a possible metabolic abnormality in LNS brains, connecting the neurological deficit to HPRT deficiency, the purine and pyrimidine nucleotide content of cultured neurons, prepared from HPRT-deficient transgenic mice, was now determined. The HPRT-deficient neuronal cultures exhibited a significantly elevated content of the pyrimidine nucleotides UTP (1.33-fold the normal level, p=0.0002) and CTP (1.28-fold the normal level, p=0.02), but normal content of the purine nucleotides ATP and GTP. This abnormality in neuronal pyrimidine nucleotide content may be associated with the pathophysiology of the neurological deficit in LNS.
Similar content being viewed by others
References
Baumeister A. A. and Frye G. D. (1985) The biochemical basis of behavioral disorder in the Lesch-Nyhan syndrome. Neurosci. Biobehav. Rev. 9, 169–178.
Breadfield X. O. and Cambi F. (1987) Purine metabolism: Lesch-Nyhan syndrome. Ann. Rev. Neurosci. 10, 533–594.
Hershfield M. S. and Seegmiller J. E. (1977) Regulation of de novo purine synthesis in human lymphoblasts. Similar rates of de novo synthesis during growth by normal cells and mutants deficient in hypoxanthine-guanine phosphoribosyltransferase. J. Biol. Chem. 252, 6002–6010.
Hooper M., Hardy K., Handyside A., Hunter S., and Monk M. (1987) HPRT-deficient mouse embryos derived from germline colonization by cultured cells. Nature 326, 292–295.
Janovitch J., Caskey T. C., Stout T. J., and Butler I. J. (1988) Lesch-Nyhan syndrome: a study of motor behaviour and cerebrospinal fluid neurotransmitters. Ann. Neurol. 23, 466–469.
Jinnah H. A., Langlais P. J., and Friedmann T. (1992) Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndrome. J. Pharmacol. Exp. Ther. 263, 596–607.
Jinnah H. A., Woicik B. E., Hunt M., Narang N., Lee K. Y., Goldstein M., et al. (1994) Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease, J. Neurosc. 14, 1164–1175.
Kelley W. N. and Wyngaarden J. B. (1983) Clinical syndromes associated with hypoxanthine-guanine phosphoribosyltransferase deficiency, in The Metabolic Basis of Inherited Disease (Stanbury, J. B., et al., eds.), McGraw-Hill, New York, pp. 1115–1143.
Lesch M. and Nyhan W. N. (1964) A familial disorder of uric acid metabolism and central nervous system function. Am J Med. 36, 561–570.
Lloyd K. G., Hornykiewicz O., Davidson L., Shannak K., Farley I., Goldstein M., et al. (1981) Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N. Engl. J. Med. 305, 1106–1116.
Nyhan W. L. (1973) The Lesch-Nyhan syndrome. Ann. Rev. Med. 24, 41–60.
Palmour R. M., Heshka T. W., and Frank E. R. (1989) Hypoxanthine accumulation and dopamine depletion in Lesch-Nyhan disease. Adv. Exp. Med. Biol. 253A, 165–172.
Pelled D., Sperling O., and Zoref-Shani E. (1999) Abnormal purine and pyrimidine nucleotide content in primary astroglia cultures from HGPRT-deficient transgenic mice. J. Neurochem. 72, 1139–1145.
Rossiter B. J. F. and Caskey C. T. (1995) Hypoxanthine-guanine phosphoribosyltransferase deficiency: Lesch-Nyhan syndrome and gout, in The Metabolic and Molecular Basis of Inherited Disease, 7th ed. (Scriver C. R., et al., eds.), McGraw-Hill, New York, pp. 1679–1706.
Seegmiller J. E., Rosenbloom F. M., and Kelley W. N. (1967) An enzyme defect associated with a sexlinked human neurological disorder and excessive purine synthesis. Science 155, 1682–1684.
Sidi Y. and Mitchell B. S. (1985) Z-nucleotide accumulation in erythrocytes from Lesch-Nyhan patients. J. Clin. Invest. 76, 2416–2419.
Watts R. W. E., Spellacy E., Gibbs D. A., Allsop J., McKeran R. O., and Salvin G. E. (1982) Clinical postmortem, biochemical and therapeutic observations on the Lesch-Nyhan syndrome with particular reference to neurological manifestations. Quart. J. Med. 201, 43–78.
Zoref-Shani E., Bromberg Y., Brosh S., Sidi Y., and Sperling O. (1993) Characterization of the alterations in purine nucleotide metabolism in hypoxanthine-guanine phosphoribosyltransferase deficientratneuroma cell line. J. Neurochem. 61, 457–463.
Zoref-Shani E., Bromberg Y., Lilling G., Gozes I., Brosh S., Sidi Y., and Sperling O. (1995) Developmental changes in purine nucleotide metabolism in cultured rat astroglia. Int. J. Develop. Neurosci. 13, 887–896.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brosh, S., Boer, P., Sperling, O. et al. Elevated UTP and CTP content in cultured neurons from HPRT-deficient transgenic mice. J Mol Neurosci 14, 87–91 (2000). https://doi.org/10.1385/JMN:14:1-2:087
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:14:1-2:087